Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

Phase 1 Completed 26 enrolled Novo Nordisk A/S

RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to investigate steady state pharmacokinetics of biphasic insulin aspart 30 and biphasic insulin aspart 70 in subjects with type 1 diabetes.

Timeline

Start: 2001-01
Primary completion: 2001-06
Completion: 2001-06

Publications

Results Chen JW, Lauritzen T, Christiansen JJ, Jensen LH, Clausen WH, Christiansen JS. Pharmacokinetic profiles of biphasic insulin aspart 30/70 and 70/30 in patients with Type 1 diabetes: a randomized double-blinded crossover study. Diabet Med. 2005 Mar;22(3):273-7. doi: 10.1111/j.1464-5491.2004.01404.x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	biphasic insulin aspart 30	Protein / enzyme biologic	—	Subcutaneous
Subject	biphasic insulin aspart 70	Unknown	—	Subcutaneous

Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

Summary

Timeline

Publications

Drugs

Indications